Position in CRBU
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,483,284
+$18,669 QoQ
Shares Held
1,410,958
+8.8% QoQ
Ownership
1.32%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 137 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 24%
Shared 0%
None 76%
Common Shares in CRBU Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. CRBU ranks #178 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in CRBU
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,483,284 | 1,410,958 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,464,615 | 1,297,167 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $1,579,165 | 993,186 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,503,448 | 1,074,442 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $1,019,213 | 808,900 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,004,722 | 1,100,465 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,813,174 | 1,769,293 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $8,957,680 | 4,570,246 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $6,826,248 | 4,162,347 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $5,740,190 | 1,116,769 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $9,128,667 | 1,593,136 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $11,026,493 | 2,306,798 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $11,693,831 | 2,751,490 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $13,977,963 | 2,632,385 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $11,579,703 | 1,843,902 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $1,851,597 | 175,507 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $397,181 | 73,146 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $179,706 | 19,576 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,360,242 | 90,142 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $820,530 | 34,375 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||